The purpose of this study is to evaluate the long-term safety of up to two gelatin-hydrogel formulation REACT injections given 3 to 6 months apart and delivered percutaneously into same kidney on renal function in participants with chronic kidney…
- Investigator
- Mark S Segal
- Ages
- 30 Years - 80 Years
- Sexes
- All